Deal Tracker · Countries
China pharma deals
31 pharma deals involving China — companies based there or deals covering the market — tracked by EPT: licensing, localization & joint ventures. Most active: Bio-Thera Solutions, Avalon Pharma, Arcera Life Sciences & Hikma Pharmaceuticals. Latest: Innogen Pharmaceuticals → Arcera Life Sciences (Licensing, 19 Nov 2026).
- EPT has tracked 31 China pharma deals (2014–2026), 18 of them announced in 2026.
- The most common structures are licensing (55%), localization (19%) & joint ventures (10%).
- Values were disclosed for 3 of 31 deals, totalling $396.5m; the largest is Livzon → Imexpharm ($221m, 11 May 2026).
- The most active companies: Bio-Thera Solutions (6), Avalon Pharma (3), Arcera Life Sciences (2) & Hikma Pharmaceuticals (2).
- Innogen Pharmaceuticals → Arcera Life SciencesLicensing · Global (LMICs) · Undisclosed · 19 Nov 2026
- Adalvo → SinoPepSupply / Manufacturing · Global (LMICs) · Undisclosed · 27 Oct 2026
- Walvax → Vaccine and Biotechnology CityTechnology transfer / Localization · MENA · Undisclosed · 26 Oct 2026
- Yichang HEC Changjiang Pharmaceutical → Pharmaniaga LifeScienceTechnology transfer / Localization · Southeast Asia · 22 Oct 2026
- Yangtze River Pharmaceutical → Pharma InvestTechnology transfer / Localization · Africa · 15 Oct 2026
- Aurisco Pharmaceutical → Avalon PharmaPartnership / Collaboration · MENA · Undisclosed · 6 Oct 2026
- Undisclosed Chinese manufacturer → Newbury PharmaceuticalsLicensing · MENA · Undisclosed · 28 Sept 2026
- Keymed Biosciences → AeiraLicensing · Southeast Asia · Undisclosed · 2 Sept 2026
- Bio-Thera Solutions → Avalon PharmaLicensing · MENA · Undisclosed · 16 Aug 2026
- IMPACT Therapeutics → PharmanoviaLicensing · Global (LMICs) · See terms · 31 Jul 2026
- Mabwell Bioscience → SaudiVaxLicensing · GCC · Undisclosed · 29 Jul 2026
- Sino Biopharmaceutical → Tempo ScanJoint venture · Southeast Asia · Undisclosed · 24 Jul 2026
- Livzon → ImexpharmM&A / Acquisition · Southeast Asia · $221m · 11 May 2026
- Fosun Pharma → Arcera Life SciencesPartnership / Collaboration · GCC · Undisclosed · 28 Apr 2026
- Hybio Pharmaceutical → MCG PharmaLicensing · Türkiye · Undisclosed · 10 Apr 2026
- Bio-Thera Solutions → Avalon PharmaLicensing · MENA · Undisclosed · 3 Feb 2026
- Sinopharm, Sinovac & Kangtai Biological Technology → AltINFARMTechnology transfer / Localization · CIS & Central Asia · $125m · 22 Jan 2026
- Minhai Biotechnology → VACSERATechnology transfer / Localization · Africa · 1 Jan 2026
- Bio-Thera Solutions → Dr. Reddy's LaboratoriesLicensing · Southeast Asia · Undisclosed · 10 Nov 2025
- BioRay Pharmaceutical → Tabuk PharmaceuticalsLicensing · MENA · Undisclosed · 29 Oct 2025
- Bio-Thera Solutions → Jamjoom PharmaLicensing · MENA · Undisclosed · 15 Sept 2025
- Bio-Thera Solutions → Tabuk PharmaceuticalsLicensing · GCC · Undisclosed · 24 Dec 2024
- Shanghai Henlius Biotech → SaudiVaxJoint venture · MENA · Undisclosed · 8 Nov 2024
- Sunshine Lake Pharma → JulpharLicensing · MENA · Undisclosed · 18 May 2023
- Shanghai Junshi Biosciences → Hikma PharmaceuticalsLicensing · MENA · See terms · 26 Dec 2022
- Huadong Medicine → JulpharPartnership / Collaboration · MENA · Undisclosed · 25 Jun 2022
- Shanghai Henlius Biotech → EurofarmaLicensing · Latin America · $50.5m · 11 May 2022
- Bio-Thera Solutions → Hikma PharmaceuticalsLicensing · Undisclosed · 27 Aug 2021
- Sinovac Biotech → VACSERATechnology transfer / Localization · Africa · Undisclosed · 1 Apr 2021
- Sinopharm → G42Joint venture · MENA · 1 Jul 2020
- Jiangsu Recbio Technology → SPIMACOLicensing · MENA · Undisclosed · 23 Jan 2014
Most active companies
Bio-Thera Solutions (6) · Avalon Pharma (3) · Arcera Life Sciences (2) · Hikma Pharmaceuticals (2) · Julphar (2) · SaudiVax (2)
Countries involved
Saudi Arabia (10) · UAE (5) · Egypt (4) · Indonesia (3) · Malaysia (3) · Vietnam (3)
Largest disclosed deals
- Livzon → Imexpharm · $221m · M&A / Acquisition · 11 May 2026
- Sinopharm, Sinovac & Kangtai Biological Technology → AltINFARM · $125m · Technology transfer / Localization · 22 Jan 2026
- Shanghai Henlius Biotech → Eurofarma · $50.5m · Licensing · 11 May 2022
Questions
- How many China pharma deals has EPT tracked?
- 31 as of 19 Nov 2026, covering 2014–2026; 18 were announced in 2026. The most recent is Innogen Pharmaceuticals → Arcera Life Sciences (Licensing, 19 Nov 2026).
- What types of China pharma deals are most common?
- Licensing: 17 (55%); Technology transfer / Localization: 6 (19%); Joint venture: 3 (10%); Partnership / Collaboration: 3 (10%).
- Which companies are most active in China pharma deals?
- Bio-Thera Solutions (6 deals), Avalon Pharma (3 deals), Arcera Life Sciences (2 deals), Hikma Pharmaceuticals (2 deals), Julphar (2 deals), SaudiVax (2 deals).
- What is the largest disclosed China pharma deal?
- Livzon → Imexpharm: $221m (M&A / Acquisition, 11 May 2026); Sinopharm, Sinovac & Kangtai Biological Technology → AltINFARM: $125m (Technology transfer / Localization, 22 Jan 2026); Shanghai Henlius Biotech → Eurofarma: $50.5m (Licensing, 11 May 2022). Values are as announced by the parties.
Browse deals
By region
GCC (83) · MENA (66) · Africa (17) · Latin America (17) · Southeast Asia (17) · Global (LMICs) (14) · CIS & Central Asia (13) · Türkiye (5) · Global ex-US (1)
By country
Saudi Arabia (69) · UAE (61) · Egypt (27) · United States (26) · Oman (20) · India (19) · Switzerland (18) · Jordan (14) · South Korea (14) · Kazakhstan (13) · Algeria (12) · Türkiye (12) · United Kingdom (11) · Brazil (10) · Kuwait (10) · Iraq (8) · Morocco (8) · Bahrain (7) · Malaysia (7) · Spain (7) · Argentina (6) · Germany (6) · Indonesia (6) · Philippines (6) · Qatar (6) · Italy (5) · Mexico (5) · Vietnam (5) · France (4) · Taiwan (4) · Tunisia (4) · Canada (3) · Chile (3) · Denmark (3) · Greece (3) · Japan (3) · Lebanon (3) · Nigeria (3) · Pakistan (3) · South Africa (3) · Sweden (3) · Thailand (3) · Azerbaijan (2) · Colombia (2) · Ireland (2) · Kenya (2) · Libya (2) · Netherlands (2) · Singapore (2) · Uruguay (2) · Uzbekistan (2)
By deal type
Licensing (56) · Distribution (41) · Technology transfer / Localization (39) · Partnership / Collaboration (35) · M&A / Acquisition (21) · Equity / Investment (18) · Joint venture (11) · Supply / Manufacturing (10)
Popular searches
MENA pharma licensing deals (25) · Saudi Arabia pharma licensing deals (24) · GCC pharma distribution deals (21) · GCC pharma partnerships (19) · China pharma licensing deals (17) · UAE pharma distribution deals (17) · GCC pharma localization & tech-transfer deals (15) · Saudi Arabia pharma distribution deals (14) · UAE pharma partnerships (13) · UAE pharma licensing deals (12) · Global (LMICs) pharma licensing deals (11) · India pharma licensing deals (11) · GCC pharma licensing deals (10) · MENA pharma partnerships (10) · Saudi Arabia pharma localization & tech-transfer deals (10) · MENA pharma localization & tech-transfer deals (9) · United States pharma licensing deals (9) · Egypt pharma localization & tech-transfer deals (8) · Saudi Arabia pharma partnerships (8) · CIS & Central Asia pharma localization & tech-transfer deals (7) · Kazakhstan pharma localization & tech-transfer deals (7) · MENA pharma distribution deals (7) · MENA pharma M&A deals (7) · United States pharma distribution deals (7)
By company
ADCAN Pharma (13) · Mubadala Bio (8) · Jamjoom Pharma (7) · SPIMACO (7) · Arcera Life Sciences (6) · Hikma Pharmaceuticals (6) · Bio-Thera Solutions (6) · Avalon Pharma (5) · Tabuk Pharmaceuticals (5) · Local Content and Government Procurement Authority (5) · Kazakhstan Ministry of Health (5) · Eva Pharma (4) · Sandoz (4) · Department of Health – Abu Dhabi (4) · Biocon (4) · Groupe Saidal (4) · Gilead Sciences (3) · Dr. Reddy's Laboratories (3) · Emirates Drug Establishment (3) · Novo Nordisk (3) · Khazaen Economic City (3) · Galenicum (3) · Roche (3) · Laprophan (3) · Sanofi (3) · Gen İlaç (3) · Taiba Healthcare (3) · Dar Al Dawa (3) · Lifera (3) · Celltrion (2) · Viatris (2) · Rem3dy Health (2) · AMA Medical Manufacturing (2) · Afreximbank (2) · M42 (2) · Abbott (2) · DKSH (2) · Adalvo (2) · Rameda (2) · Menarini (2) · Korea United Pharm (2) · Samsung Bioepis (2) · AstraZeneca (2) · MS Pharma (2) · LifePharma (2) · Duopharma Biotech (2) · JCR Pharmaceuticals (2) · Philex Pharmaceuticals (2) · Lotus Pharmaceutical (2) · Elpen (2) · Dhofar Pharmaceutical Industries (2) · Accord Healthcare (2) · CCL Pharmaceuticals (2) · Abdi İbrahim (2) · Nordic Pharma (2) · UNIMED Laboratories (2) · Minapharm (2) · SaudiVax (2) · Faes Farma (2) · AJA Pharma (2) · VACSERA (2) · Bayer (2) · Shanghai Henlius Biotech (2) · Julphar (2)
By therapeutic area
Multi-therapy (64) · Oncology (30) · Metabolic / Diabetes (27) · Cardiovascular (17) · Vaccines (15) · Immunology / Inflammation (13) · Rare / Orphan (9) · Infectious Disease (8) · CNS / Neurology (6) · Ophthalmology (6) · Consumer health (5) · Women's Health (4) · Respiratory (2)